| Interstitial fibrosis and tubular atrophy (IFTA) is associated with a significant economic burden in Germany |
| Author(s): Machnicki G1, Kotowa W2, Reichelt A2, Pirk O2, Naujoks C3 |
| Affiliations(s): 1 Novartis Pharmaceuticals Corporation, East Hanover, NJ, US 2 IMS HEALTH GmbH & Co. OHG, Nuremberg, Germany 3 Novartis Pharma AG, Basel, Switzerland. |
| Publication(s): J Am Soc Nephrol 20: SA-PO308, 2009 |
| Document Type(s): Abstract |
| Countries: Germany |
C:
Y: |
Nephrology
2009 |
|
L:
A: |
English
|
|
 |
| |
| |
| Verbrauch von Erythropoese-stimulierenden Faktoren in der Therapie der renalen Anämie - eine „real life“- Analyse der Versorgungssituation in Deutschland [Consumption of erythropoietin-stimulating factors in the renal anaemia therapy - a "real life"-analysis of the German medical treatment situation] |
| Author(s): Schöffski O1, Müller H-J2, Kostev K3, Claus V4 |
| Affiliations(s): 1 University Erlangen-Nuremberg, Nuremberg, Germany 2 Med. Klinik III Klinikum Fulda gAG, Fulda, Germany 3 IMS Health, Frankfurt, Germany 4 IMS Health, Munich, Germany |
| Publication(s): Congress for nephrology, Göttingen, Germany, 26-29 September 2009 |
| Document Type(s): Abstract, Poster |
| Countries: Germany |
C:
Y: |
Health economics, Hematology, Nephrology
2009 |
|
L:
A: |
German
Retrospective database analysis |
|
|
| |
| |
| Cost-effectiveness of immunosuppressive regimens in renal transplant recipients in Germany |
| Author(s): Hass B1, Arns W2, Kuchenbecker U3, Juergensen JS4 |
| Affiliations(s): 1 IMS Health, Nuremberg, Germany 2 Kliniken der Stadt Koeln, Cologne, Germany 3 Wyeth Pharma, Muenster, Germany 4Charité-
Universitaetsmedizin, Berlin, Germany |
Publication(s): ISPOR 13th Annual International Congress, May 3-7, 2008 ,Toronto, Canada
Value in Health, 11(3): A302, 2008 |
| Document Type(s): Abstract, Oral presentation |
| Countries: Germany |
C:
Y: |
Nephrology
2008 |
|
L:
A: |
English
Cost effectiveness |
|
|
| |
| |
| A retrospective matched cohort study of the burden of secondary hyperparathyroidism (SHPT) in predialysis patients without Vitamin D Receptor (VDR) activator therapy |
| Author(s): Marx S, Kalantar-Zadeh K, Schumock GT, Melnick JZ, Sterz R, Joyce AT, Smith PJ, Sacks NC, Blakesley VA |
| Affiliations(s): |
| Publication(s): ISPOR 12th Annual International Meeting, May 19-23, 2007 |
| Document Type(s): Poster |
| Countries: |
C:
Y: |
Nephrology
2006 |
|
L:
A: |
English
Burden of illness |
|
|
| |
| |
| Cost utility analysis of cinacalcet in addition to standard of care in the UK. |
| Author(s): Ray JA, Valentine WJ, Palmer AJ. |
| Affiliations(s): |
| Publication(s): Nephrol Dial Transplant. 2007 Sep 4; |
| Document Type(s): Manuscript in preparation |
| Countries: UK |
C:
Y: |
Nephrology
2006 |
|
L:
A: |
English
Cost utility |
|
|
| |
| |
| Efficacy of botulinum toxin type A (BoNTA) in the treatment of adult spasticity: a meta-analysis of response rate using individual patient data |
| Author(s): Aldridge G, Frost M, Le Reun C, Lynch M, Davey P, Napier-Flood F. |
| Affiliations(s): |
| Publication(s): ISPOR 2nd Asia-Pacific conference, Worldfield Convention Hotel, Shanghai, China |
| Document Type(s): Poster |
| Countries: |
C:
Y: |
Nephrology, Neurological disorders
2006 |
|
L:
A: |
English
Meta analysis, Quality of life |
|
|
| |
| |
| Health economic consequences of the use of irbesartan in patients with type 2 diabetes, hypertension and nephropathy in Switzerland. |
| Author(s): Frei A, Palmer AJ, Burnier M, Hess B |
| Affiliations(s): |
| Publication(s): Schweiz Rundsch Med Prax.15;95:401-8. German. |
| Document Type(s): Manuscript in preparation |
| Countries: |
C:
Y: |
Nephrology
2006 |
|
L:
A: |
English
|
|
|
| |
| |
| Potential savings with everolimus with reduced-dose cyclosporine compared to mycophenolate motefil with full dose cyclosporine in de novo renal transplant recipients in China. |
| Author(s): Yang X, Ethgen O, Wang W, Lian R, Ricci JF, Spaepen E et al. |
| Affiliations(s): |
| Publication(s): ISPOR 2nd Asia-Pacific Congress, Shanghai, China |
| Document Type(s): Poster |
| Countries: China |
C:
Y: |
Nephrology
2006 |
|
L:
A: |
English
|
|
|
| |
| |
| Cost-effectiveness of sirolimus therapy with early cyclosporin withdrawal versus long-term cyclosporin therapy in Australia |
| Author(s): Gordois A, Nobes M, Toohey M, Russ G |
| Affiliations(s): |
| Publication(s): Clinical Transplantation. 20:4, 526–536 |
| Document Type(s): Article |
| Countries: Australia |
C:
Y: |
Nephrology
2006 |
|
L:
A: |
English
Cost effectiveness |
|
|
| |
| |
| A regional Asian analysis of the cost-effectiveness of early irbesartan treatment verus conventional antihypertension treatment, and late irbesartan treatment in patients with type 2 diabetes hypertension and kidney disease |
| Author(s): Annemans L, Demarteau N, Hu S, Lee TJ, Morad Z, Thanom S, Yang WC. |
| Affiliations(s): |
| Publication(s): ISPOR 2nd Asia-Pacific conference, Worldfield Convention Hotel, Shanghai, China |
| Document Type(s): Poster |
| Countries: |
C:
Y: |
Endocrinology, Nephrology
2006 |
|
L:
A: |
English
|
|
|
| |
| |
 4 of 4
|
